New drug could free kidney patients from lifelong Anti-Rejection pills
NCT ID NCT05806749
Summary
This early-stage study is testing if adding the drug belumosudil to a special kidney and stem cell transplant procedure can help patients safely stop taking lifelong anti-rejection medications. The goal is to see if the body can learn to accept the new kidney without needing constant drugs to suppress the immune system. Researchers will enroll 16 carefully selected adult patients to check the safety of this approach and see if it leads to successful medication withdrawal.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California, Los Angeles
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.